Addiction Medicine Journal Club: Pre-op Depression and Anxiety and Long-Term Post-op Opioid Use - Audio_Episode 9

Addiction is a disease that can be treated, and this podcast will help you stay up to date with the latest research that you can use in your addiction medicine practice. In this episode of Addiction Medicine Journal Club we discuss an article describing the association between   pre-op depression and anxiety and long-term post-op opioid use.

Article citation: Carey ET, Moore KJ, Young JC, Bhattacharya M, Schiff LD, Louie MY, Park J, Strassle PD. Association of Preoperative Depression and Anxiety With Long-term Opioid Use After Hysterectomy for Benign Indications. Obstet Gynecol. 2021 Nov 1;138(5):715-724. doi: 10.1097/AOG.0000000000004568. PMID: 34619742; PMCID: PMC8547203.

In our introduction we discuss how the Americans with Disabilities Act protects people with opioid use disorder. The newest federal guidance is here https://www.ada.gov/opioid_guidance.pdf .

If you want your comments about this article included in a future episode, leave them in your CME quiz, email us at [email protected], talk to us on Twitter @AddicionMedJC, or even record a comment using the voice memo app on your phone and email it to us. Thank you for being part of the conversation.

Credits
Host: Sonya Del Tredici, MD
Host: John Keenan, MD
Music: Benjamin Kennedy
Audio Production: Angela Ohlfest
CME Coordinator: georgeanna ledgerwood, MLIS/LMT
Sponsor: WellSpan Health

**PLEASE NOTE: to claim MOC credit for this activity, after completion of the activity and evaluation, you will need to go to the evaluation page and click "Claim MOC."**

1. Summarize the main results from the article regarding association between pre-op depression and anxiety and long-term post-op opioid use in patients undergoing hysterectomy for benign disease
2. Analyze how the conclusions of the featured article will affect current perioperative opioid prescribing
3. Discuss the association between pre-op depression and anxiety and long-term post-op opioid use in patients undergoing hysterectomy for benign disease

AMA PRA Category 1 Credits™ (0.50 hours), Non-Physician Attendance (0.50 hours), Act 13 Patient Safety/Risk Management Credits (0.50 hours), Act 124 Opioid Continuing Education Qualified (0.50 hours), ABS CC SAM (0.50 hours)

Monday, June 13, 2022, 12:00 AM - Sunday, December 31, 2023, 11:59 PM

Accreditation Statement: WellSpan Health is accredited by the Pennsylvania Medical Society to provide continuing medical education for physicians. 

Credit Designation: WellSpan Health designates this Enduring Material activity for a maximum of 0.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

All faculty participating in continuing medical education programs sponsored by WellSpan Health are expected to disclosure to the program audience whether they do or do not have any real or apparent conflict(s) of interest or other relationships related to the content of their presentation(s).

Mitigation of Relevant Financial Relationships

WellSpan Health CME adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.